05/12/2025
We are honoured to present our new article in the American Journal of Otolaryngology, resulting from a dedicated .niguarda . In it, we detail our institutional experience in implementing adjunctive dual biologic therapy for persistent and difficult-to-treat ENT patients. This work reflects our commitment to advancing the management of chronic inflammatory sinonasal disease through evidence-based, biologic-guided protocols, optimizing outcomes while minimizing the burden of repeated surgery or systemic steroids. We trust that our findings will contribute to consolidating best practices and support colleagues worldwide in refining biologic-care pathways. Sincere thanks to all contributors — proud to uphold scientific excellence and patient-centred care.
niguarda